Our data supports the existence of a novel feedforward loop involving the HIF-1α- Pol ι-USP7 regulatory axis in ESCC cells, which offers a promising potential therapeutic target to address the rapid progression and therapeutic resistance observed in this disease. The gene discussed is HIF1A; the disease is esophageal squamous cell carcinoma.